A depressed adolescent at high risk of suicidal behavior

American Journal of Psychiatry

Volumn 165, Issue 3, 2008, Pages 323-328

  Vitiello, Benedetto ^a   Pearson, Jane L ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PARACETAMOL; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ARTICLE; CASE REPORT; COGNITIVE THERAPY; DRUG OVERDOSE; FAMILY HISTORY; GENERALIZED ANXIETY DISORDER; HIGH RISK POPULATION; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOCIAL PHOBIA; STOMACH LAVAGE; SUICIDAL BEHAVIOR; SUICIDE ATTEMPT; CHILD PSYCHOLOGY; DRUG ADMINISTRATION; INTOXICATION; MULTIMODALITY CANCER THERAPY; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL MODEL; STATISTICS; SUICIDE;

ACETAMINOPHEN; ADOLESCENT; ADOLESCENT PSYCHOLOGY; ANTIDEPRESSIVE AGENTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DRUG ADMINISTRATION SCHEDULE; FLUOXETINE; HUMANS; MALE; MODELS, PSYCHOLOGICAL; OVERDOSE; RISK FACTORS; SEROTONIN UPTAKE INHIBITORS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 42449104894     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2007.07101549     Document Type: Article

References (35)

1. Poznanski EO, Mokros HB: Manual for the Children's Depression Rating Scale - Revised. Los Angeles, Western Psychological Services, 1995
2. Reynolds WM: Suicidal Ideation Questionnaire: Professional Manual. Lutz, Fla, Psychological Assessment Resources, Inc, 1991
3. Posner K, Oquendo MA, Gould M, Stanley B, Davies M: Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007; 164:1035-1043
4. Bridge JA, Goldstein TR, Brent DA: Adolescent suicide and suicidal behavior. J Child Psychol Psychiatry 2006; 47:372-394
5. Eaton DK, Kann L, Kinchen S, Ross J, Hawkins J, Harris WA, Lowry R, McManus T, Chyen D, Shanklin S, Lim C, Grunbaum JA, Wechsler H: Youth Risk Behavior Surveillance: United States, 2005. J Sch Health 2006; 76:353-372
6. Swahn MH, Bossarte RM: Gender, early alcohol use, and suicide ideation and attempts: findings from the 2005 Youth Risk Behavior Survey. J Adolesc Health 2007; 41:175-181
7. Centers for Disease Control and Prevention: 2004 United States Suicide Injury Deaths and Rates. Atlanta, National Center for Injury Prevention and Control, 2007 (http://webappa.cdc.gov/sasweb/ncipc/mortrate10_sy.html)
8. Brent DA, Kolko DJ, Wartella ME, Boylan MB, Moritz G, Baugher M, Zelenak JP: Adolescent psychiatric inpatients' risk of suicide attempt at 6-month follow-up. J Am Acad Child Adolesc Psychiatry 1993; 32:95-105
9. Goldston DB, Daniel SS, Reboussin BA, Reboussin DM, Kelley AE, Frazier PH: Psychiatric diagnoses of previous suicide attempters, first-time attempters, and repeat attempters on an adolescent inpatient psychiatric unit. J Am Acad Child Adolesc Psychiatry 1998; 37:924-932
10. Shaffer D, Gould MS, Fisher P, Trautman P, Moreau D, Kleinman M, Flory M: Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996; 53:339-348
11. Gould MS, Greenberg T, Velting DM, Shaffer D: Youth suicide risk and preventive interventions: a review of the past 10 years. J Am Acad Child Adolesc Psychiatry 2003; 42:386-405
12. Ashworth J: Practice Principles: A Guide for Mental Health Clinicians Working With Suicidal Children and Youth. Vancouver, Ministry of Children and Family Development, British Columbia, 2001. http://www.mcf.gov.bc.ca/ mental_health/pdf/suicid_prev_manual.pdf
13. Beck AT, Kovacs M, Weissman M: Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979; 47:343-352
14. Spirito A, Boergers J, Donaldson D, Bishop D, Lewander W: An intervention trial to improve adherence to community treatment by adolescents after a suicide attempt. J Am Acad Child Adolesc Psychiatry 2002; 41:435-442
15. Weisz JR, McCarthy CA, Valeri SM: Effects of psychotherapy for depression in children and adolescents: a meta-analysis. Psychol Bull 2006; 132:132-149
16. Bridge JA, Iyengar S, Salary CB, Barbe RP, Birmaher B, Pincus HA, Ren L, Brent DA: Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007; 297:1683-1696
17. Hammad TA, Laughren T, Racoosin J: Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry 2006; 63:332-339
18. Mufson L, Dorta KP, Wickramaratne P, Nomura Y, Olfson M, Weissman MM: A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents. Arch Gen Psychiatry 2004; 61:577-584
19. Brent D, Poling K: Cognitive Therapy Treatment Manual for Depressed and Suicidal Youth. Pittsburgh, Star Center, 1997
20. Curry JF, Wells KC: Striving for effectiveness in the treatment of adolescent depression: cognitive behavior therapy for multisite community intervention. Cogn Behav Pract 2005; 12:177-185
21. The TADS Team: Fluoxetine, cognitive behavior therapy, and their combination for adolescents with depression. JAMA 2004; 292:807-820
22. Kennard B, Silva S, Vitiello B, Curry J, Kratochvil C, Simons A, Hughes J, Feeny N, Weller E, Sweeney M, Reinecke M, Pathak S, Ginsburg G, Emslie G, March J; TADS Team: Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1404-1411
23. Vitiello B, Rohde P, Silva S, Wells K, Casat C, Waslick B, Simons A, Reinecke M, Weller E, Kratochvil C, Walkup J, Pathak S, Robins M, March J; TADS Team: Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1419-1426
24. Goodyer I, Dubicka B, Wilkinson P, Kelvin R, Roberts C, Byford S, Breen S, Ford C, Barrett B, Leech A, Rothwell J, White L, Harrington R: Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behavior therapy in adolescents with major depression: randomized controlled trial. BMJ 2007; 335:142-149
25. Goodman WK, Murphy TK, Storch EA: Risk of adverse behavioral effects with pediatric use of antidepressants. Psychopharmacology (Berl) 2007; 191:87-96
26. US Food and Drug Administration: Antidepressant Use in Children, Adolescents, and Adults: Revisions to Product Labeling. http://www. fda.gov/cder/drug/antidepressant s/antidepressants_label_change_2007.pdf
27. Libby AM, Brent DA, Morrato EH, Orton HD, Allen R, Valuck RJ: Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. Am J Psychiatry 2007; 164:884-891
28. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RMC, Mann JJ: Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. Am J Psychiatry 2007; 164:1356-1363
29. The TADS Team: The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007; 64:1132-1144
30. Brown GK, Ten Have T, Henriques GR, Xie SX, Hollander JE, Beck AT: Cognitive therapy for the prevention of suicide attempts: a randomized controlled trial. JAMA 2005; 294:563-570
31. Linehan MM, Comtois KA, Murray AM, Brown MZ, Gallop RJ, Heard HL, Korslund KE, Tutek DA, Reynolds SK, Lindenboim N: Two-year randomized controlled trial and follow-up of dialectical behavior therapy versus therapy by experts for suicidal behaviors and borderline personality disorder. Arch Gen Psychiatry 2006; 63:757-766
32. Brunstein Klomek A, Stanley B: Psychosocial treatment of depression and suicidality in adolescents. CNS Spectr 2007; 12:135-144
33. Morrato EH, Libby AM, Orton HD, deGruy FV III, Brent DA, Allen R, Valuck RJ: Frequency of provider contact after FDA advisory on suicidal risk of pediatric suicidality with SSRIs. Am J Psychiatry 2008; 165:42-50
34. Bhatia S, Rezac AJ, Vitiello B, Sitorius MA, Buehler BA, Kratochvil CJ: Antidepressant prescribing practices for the treatment of children and adolescents. J Child Adolesc Psychopharmacology (in press)
35. US Food and Drug Administration: Revision to Medication Guide: Antidepressant Medicines, Depression and Other Serious Mental Illnesses, and Suicidal Thoughts or Actions. Revised May 2, 2007. http://www.fda.gov/cder/drug/ antidepressants/antidepressants_MG_2007.pdf